ENDOXAN Safety Questions, ENDOXAN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about ENDOXAN. Our extensive database of ENDOXAN adverse events and ENDOXAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about ENDOXAN
ENDOXAN Safety Reports
Total ENDOXAN reports: 170.ENDOXAN FDA safety alerts: No.
Reported deaths: 41 Reported hospitalizations: 102.
Take ENDOXAN Side Effects Survey or Share Your ENDOXAN Story. Read More Here.
Showing 1-75 of 170 Next >
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on May 23, 2007. Female patient, 48 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia. ENDOXAN dosage: unknown. Patient died on 04/29/2007.ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Male patient, 73 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. ENDOXAN dosage: unknown. During the same period patient was treated with ELDISINE, MABTHERA, FARMORUBICINE, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on May 31, 2007. Female patient, 61 years of age, was diagnosed with burkitt's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, cardiac failure acute, condition aggravated, pancytopenia. ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, MABTHERA, ONCOVIN, PERINDOPRIL ERBUMINE, FOZITEC. Patient died on 05/28/2007.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma, stem cell transplant and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, back pain, delirium, rhabdomyolysis. ENDOXAN dosage: unknown. During the same period patient was treated with GASTER D, MUCOSTA, DIFLUCAN, MAGNESIUM OXIDE, PURSENNID. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on June 12, 2007. Male patient, 70 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, transitional cell carcinoma. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, FLUDARA, MABTHERA, PEGINTERFERON ALFA, DIAMICRON, STAGID, TICLID. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Female patient, 70 years of age, was diagnosed with vasculitis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. ENDOXAN dosage: unknown. During the same period patient was treated with UROMITEXAN, OSTRAM. Patient recovered.
Consumer or non-health professional from FRANCE reported ENDOXAN problem on June 20, 2007. Female patient, 68 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, cardiac arrest, dyspraxia, mental status changes, neurological examination abnormal. ENDOXAN dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MEDROL, FUROSEMIDE, GLUCOPHAGE, TENORMIN, MINIPRESS, DAFALGAN, INSULIN. Patient was hospitalized. Patient died on 02/24/2005.
ENDOXAN problem was reported by a Health Professional from UNITED STATES on June 22, 2007. Male patient, child 2 years of age, was diagnosed with ependymoma, candida sepsis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, altered state of consciousness, bone marrow failure, candidiasis, central line infection, constipation, electrolyte imbalance, febrile neutropenia, haemoglobin decreased. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE SULPHATE, ITRACONAZOLE, CISPLATIN, MICAFUNGIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on June 19, 2006. Female patient, 43 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUOROURACIL. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 59 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, enuresis, leukopenia. ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, TAXOTERE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on June 30, 2006. Male patient, 83 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: hepatitis b. ENDOXAN dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 04, 2006. Female patient, 57 years of age, was diagnosed with multiple sclerosis, back pain and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, nausea, vomiting. ENDOXAN dosage: unknown. During the same period patient was treated with OXCARBAZEPINE, IMOVANE, BACLOFEN, PARACETAMOL, VASOBRAL, ZALDIAR. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported ENDOXAN problem on July 05, 2006. Male patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: emphysema, pancreatitis. ENDOXAN dosage: unknown. During the same period patient was treated with VINCREX SULPHATE, PREDNISOLONE, DEXAMETHASONE, PIRARUBICIN. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Health Professional from UNITED STATES on July 13, 2006. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, encephalopathy, pancytopenia, stomatitis. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CARDIOXANE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 13, 2006. Male patient, 56 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, peritonitis. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, ONCOVIN, ADRIAMYCIN PFS, CYTARABINE, METHOTREXATE, PREDNISOLONE, BLEOMYCIN. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 74 years of age, was diagnosed with mycosis fungoides and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, THERARUBICIN, ONCOVIN, PREDNISOLONE. Patient died.
Health Professional from JAPAN reported ENDOXAN problem on July 14, 2006. Male patient, 48 years of age, was diagnosed with lymphoma, hiv infection and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, coma, hepatic failure, malignant neoplasm progression, platelet count decreased, somnolence, white blood cell count decreased. ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, LASTET, IFOMIDE, PARAPLATIN, PREDNISOLONE, DECADRON, STOCRIN. Patient was hospitalized. Patient died on 04/29/2005.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, 20 years of age, was diagnosed with bone marrow conditioning regimen and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hyponatraemia, mucous membrane disorder, pyrexia, rectal haemorrhage, renal tubular acidosis. ENDOXAN dosage: unknown. During the same period patient was treated with LYMPHOGLOBULINE, UROMITEXAN, BACTRIM, FLUDARA, LIPLE, GASTER. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 25, 2006. Female patient, 59 years of age, was diagnosed with pemphigoid, hypertension, diabetes mellitus and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, lymphopenia, pneumonia. ENDOXAN dosage: unknown. During the same period patient was treated with FUROSEMIDE, GLICLAZIDE, PREDNISOLONE. Patient was hospitalized and became disabled. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Male patient, child 10 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against transplant rejection, infection prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, c-reactive protein increased, diarrhoea, graft versus host disease, hyponatraemia, liver disorder, oral mucosal disorder. ENDOXAN dosage: unknown. During the same period patient was treated with ZETBULIN, TACROLIMUS, ANTILYMPHOCYTE IMMUNOGLOBULIN, BACTRIM, BROACT, CRAVIT, VALTRAX. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported ENDOXAN problem on Aug 01, 2006. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: chalazion, neutrophil count decreased, white blood cell count decreased. ENDOXAN dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, RINDERON, KYTRIL, PURSENNID. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2005. Female patient, 68 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, peripheral sensory neuropathy. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, ADRIAMYCIN PFS, ARACYTINE, ONCOVIN, PREDNISONE, RITUXIMAB. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Feb 02, 2006. Male patient, 57 years of age, was diagnosed with chronic lymphocytic leukaemia refractory and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hepatic enzyme, hepatic enzyme increased, lymphoma transformation, malaise. ENDOXAN dosage: unknown. During the same period patient was treated with MABCAMPATH, FLUDARA, MITOXANTRONE, LANSOPRAZOLE, ACYCLOVIR. Patient was hospitalized. Patient died on 11/26/2005.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Male patient, 36 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: transaminases increased. ENDOXAN dosage: unknown. During the same period patient was treated with ZOPHREN, NEURONTIN, RIVOTRIL, TROSPIUM CHLORIDE, AVONEX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 13, 2006. Female patient, 37 years of age, was diagnosed with systemic sclerosis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, pneumonia aspiration, pyrexia. ENDOXAN dosage: unknown. During the same period patient was treated with UROMITEXAN, ESOMEPRAZOLE MAGNESIUM, NIFEDIPINE, FOLACIN, PREDNISOLONE, VALPROIC ACID, NABUMETONE, CALCICHEW. Patient recovered.
ENDOXAN problem was reported by a Health Professional from ITALY on Aug 07, 2006. Female patient, 74 years of age, was diagnosed with arteritis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, coma, depressed level of consciousness, dyspnoea, hepatic failure, hyperthermia, jaundice, metabolic acidosis, rash. ENDOXAN dosage: unknown. During the same period patient was treated with MEDROL, TENORMIN, ASPIRIN, ESOMEPRAZOLE MAGNESIUM, SINVACOR, FOSAMAX. Patient was hospitalized. Patient died on 07/14/2006.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 07, 2006. Female patient, 47 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, hepatitis. ENDOXAN dosage: unknown. During the same period patient was treated with LASILIX, TRIATEC, ZOPHREN, UROMITEXAN, DOPAMINE, DOBUTAMINE, METHYLPREDNISOLONE, ALDACTONE. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, encephalopathy, pancytopenia, stomatitis. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CARDIOXANE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 14, 2006. Male patient, 74 years of age, was diagnosed with mycosis fungoides and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, THERARUBICIN, ONCOVIN, PREDNISOLONE, GABEXATE MESILATE. Patient died.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 48 years of age, was diagnosed with lymphoma, acquired immunodeficiency syndrome and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cerebral haemorrhage, coma, hepatic failure, malignant neoplasm progression, platelet count decreased, somnolence, white blood cell count decreased. ENDOXAN dosage: unknown. During the same period patient was treated with LASTET, IFOMIDE, PARAPLATIN, STOCRIN, ZERIT, ONCOVIN, ADRIAMYCIN PFS, ZEFIX. Patient was hospitalized. Patient died on 04/28/2005.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 24, 2006. Male patient, 20 years of age, was diagnosed with bone marrow conditioning regimen and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, c-reactive protein increased, graft versus host disease, hyponatraemia, mucous membrane disorder, pyrexia, renal tubular acidosis. ENDOXAN dosage: unknown. During the same period patient was treated with LYMPHOGLOBULINE, UROMITEXAN, BACTRIM, FLUDARA, LIPLE, GASTER. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Male patient, child 10 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against transplant rejection, infection prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, c-reactive protein increased, diarrhoea, graft versus host disease, hyponatraemia, infection in an immunocompromised host, liver disorder, neutrophil count decreased, oral mucosal disorder. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, ZETBULIN, TACROLIMUS, ANTILYMPHOCYTE IMMUNOGLOBULIN, BACTRIM, BROACT, LEVOFLOXACIN, VALTRAX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 21, 2006. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatitis. ENDOXAN dosage: unknown. During the same period patient was treated with FARMORUBICIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Health Professional from FRANCE on Aug 23, 2006. Male patient, 59 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: erythema, photosensitivity reaction, pruritus. ENDOXAN dosage: unknown. During the same period patient was treated with BACTRIM, ALLOPURINOL, MABTHERA, FLUDARABINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 23, 2006. Male patient, 78 years of age, was diagnosed with plasmacytoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: herpes zoster. ENDOXAN dosage: unknown. During the same period patient was treated with PREDONINE, ADRIAMYCIN PFS, ONCOVIN. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Male patient, child 3 years of age, was diagnosed with congenital aplastic anaemia, infection prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: enterocolitis, graft versus host disease, hepatic function abnormal, pneumonia, sepsis, venoocclusive liver disease. ENDOXAN dosage: unknown. During the same period patient was treated with FUNGIZONE, PREDONINE, METHYLPREDNISOLONE, CYCLOSPORINE, ALKERAN, FLUDARA, LYMPHOGLOBULINE, DENOSINE. Patient died on 06/13/2005.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Mar 20, 2006. Male patient, child 3 years of age, was diagnosed with congenital aplastic anaemia, infection prophylaxis, venoocclusive liver disease and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: enteritis infectious, graft versus host disease, hepatic function abnormal, pneumonitis, sepsis. ENDOXAN dosage: unknown. During the same period patient was treated with FUNGIZONE, METHYLPREDNISOLONE, CYCLOSPORINE, ALKERAN, FLUDARA, LYMPHOGLOBULINE, DENOSINE, HEPARIN. Patient died on 06/13/2005.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2006. Male patient, 84 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, cerebrovascular accident, hemiplegia. ENDOXAN dosage: unknown. During the same period patient was treated with VEPESID, LASILIX, FUNGIZONE, SOLUPRED. Patient died on 08/29/2006.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 14, 2006. Male patient, 46 years of age, was diagnosed with lymphoma, acquired immunodeficiency syndrome and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, brain stem haemorrhage, cerebral haemorrhage, coma, disease progression, hepatic encephalopathy, hepatic failure, hypocoagulable state, immunodeficiency. ENDOXAN dosage: unknown. During the same period patient was treated with LASTET, IFOMIDE, PARAPLATIN, STOCRIN, ZERIT, ONCOVIN, ADRIAMYCIN PFS, ZEFIX. Patient was hospitalized. Patient died on 04/28/2005.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatitis. ENDOXAN dosage: unknown. During the same period patient was treated with FARMORUBICIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Sept 19, 2006. Male patient, 51 years of age, was diagnosed with multiple myeloma, chest wall mass and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, platelet count decreased, thrombophlebitis. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, THALIDOMIDE, DEXAMETHASONE, ADRIAMYCIN PFS, ONCOVIN, CYMERIN, PREDONINE. Patient died.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 46 years of age, was diagnosed with lymphoma, acquired immunodeficiency syndrome and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, autoimmune disorder, cerebral haemorrhage, coma, hepatic cirrhosis, hepatic encephalopathy, hepatic failure, jaundice, lymphoma. ENDOXAN dosage: unknown. During the same period patient was treated with LASTET, IFOMIDE, PARAPLATIN, STOCRIN, ONCOVIN, ADRIAMYCIN PFS, ZEFIX, ZERIT. Patient was hospitalized. Patient died on 04/29/2005.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Sept 28, 2006. Male patient, 69 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. ENDOXAN dosage: unknown. During the same period patient was treated with RITUXAN, ONCOVIN. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Female patient, 42 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FARMORUBICIN, KYTRIL, DECADRON. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Oct 12, 2006. Male patient, 43 years of age, was diagnosed with diffuse large b-cell lymphoma stage ii and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, renal failure acute. ENDOXAN dosage: unknown. During the same period patient was treated with CARBOPLATIN, RITUXAN, CYMERIN, ETOPOSIDE, HEMATOPOETIC PROGENITOR CELLS. Patient was hospitalized. Patient died.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Male patient, 20 years of age, was diagnosed with renal transplant and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: hepatitis. ENDOXAN dosage: unknown. During the same period patient was treated with BACTRIM, PREDNISOLONE, CYCLOSPORINE, SIMULECT. Patient recovered.
Consumer or non-health professional from FRANCE reported ENDOXAN problem on Oct 13, 2006. Female patient, 62 years of age, was diagnosed with breast cancer, breast cancer stage iii and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, pancytopenia. ENDOXAN dosage: unknown. During the same period patient was treated with TAXOL, NAVELBINE, HERCEPTIN, ADRIAMYCIN PFS. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, EPIRUBICIN, CISPLATIN, PACLITAXEL, CARBOPLATIN, TAXOTERE. Patient died.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 19, 2006. Female patient, 27 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FARMORUBICIN. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Male patient, 29 years of age, was diagnosed with renal transplant and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: hepatitis, renal failure, renal haematoma, renal tubular necrosis, transplant rejection. ENDOXAN dosage: unknown. During the same period patient was treated with BACTRIM, PREDNISOLONE, LANSOPRAZOLE, ISCOTIN, PYDOXAL, ZOVIRAX, SELBEX, NEORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Oct 20, 2006. Female patient, 62 years of age, was diagnosed with b-cell lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: headache, nausea, vomiting. ENDOXAN dosage: unknown. During the same period patient was treated with VEPESID, ZANTAC, METHYLPREDNISOLONE, ZOFRAN, MESNA. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 61 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, malaise, shock, vomiting. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUOROURACIL, FARMORUBICIN, KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Oct 26, 2006. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: deafness neurosensory. ENDOXAN dosage: unknown. During the same period patient was treated with THALIDOMIDE, PENTAMIDINE ISETHIONATE, ZOMETA, DEXAMETHASONE. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2006. Male patient, 32 years of age, weighting 119.0 lb, was diagnosed with testicular choriocarcinoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anxiety, bacterial infection, bradycardia, brain oedema, cerebral ischaemia, enterococcal infection, escherichia infection. ENDOXAN dosage: unknown. During the same period patient was treated with ADRIBLASTINE, ETOPOSIDE TEVA, LENOGRASTIM. Patient died on 09/14/2006.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Oct 30, 2006. Female patient, 40 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, dyspnoea, palpitations, pulmonary oedema. ENDOXAN dosage: unknown. During the same period patient was treated with FARMORUBICIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2006. Female patient, 38 years of age, was diagnosed with systemic lupus erythematosus, pneumocystis jiroveci pneumonia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia, pyrexia, respiratory failure. ENDOXAN dosage: unknown. During the same period patient was treated with BACTRIM, PREDNISOLONE, PENTAMIDINE ISETHIONATE. Patient died.
Health Professional from UNITED STATES reported ENDOXAN problem on Nov 08, 2006. Female patient, 64 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis superficial. ENDOXAN dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, CHLORIDE, GLUCOSE. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cold sweat, dizziness, hepatic function abnormal, malaise, nausea, vomiting. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUOROURACIL, FARMORUBICIN, KYTRIL, DECADRON, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 08, 2006. Female patient, 65 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: thrombosis. ENDOXAN dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, CHLORIDE, GLUCOSE. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Physician from FRANCE on Nov 11, 2006. Male patient, 55 years of age, was diagnosed with polymyositis, chronic myeloid leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, condition aggravated. ENDOXAN dosage: unknown. During the same period patient was treated with CORTICOSTEROID NOS, GLEEVEC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 16, 2006. Female patient, 41 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis. ENDOXAN dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, CHLORIDE, GLUCOSE. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 61 years of age, was diagnosed with metastases to skin and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cold sweat, dizziness, malaise, nausea, vomiting. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FARMORUBICIN, KYTRIL, DECADRON, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 21, 2006. Female patient, 32 years of age, was diagnosed with lupus nephritis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: arthritis, hyperkalaemia, hypersensitivity, pyrexia, thrombosis. ENDOXAN dosage: unknown. During the same period patient was treated with PREDONINE, BACTRIM, WARFARIN, MUCOSTA, ONEALFA, PARIET, RENIVACE, FERROMIA. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Male patient, child 8 years of age, was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: epilepsy, haemorrhage intracranial, intracranial pressure increased, subdural haematoma, thrombocytopenia. ENDOXAN dosage: unknown. During the same period patient was treated with CELEBREX, ETOPOSIDE, PHENYTOIN CAP, TEGRETOL, RIVOTRIL, OMEPRAZOLE, SOLUPRED, ZOFRAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 28, 2006. Female patient, 63 years of age, was diagnosed with burkitt's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, bacterial sepsis, mucosal inflammation. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, MABTHERA, ONCOVIN. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2006. Male patient, child 4 years of age, was diagnosed with malignant neoplasm of pleura and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, CISPLATIN, VINCRISTINE SULPHATE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Dec 11, 2006. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUOROURACIL. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, 20 years of age, was diagnosed with hodgkin's disease and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: non-hodgkin's lymphoma. ENDOXAN dosage: unknown. During the same period patient was treated with PREDONINE, ONCOVIN, PROCARBAZINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Dec 05, 2006. Male patient, child 4 years of age, was diagnosed with malignant neoplasm of pleura and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia. ENDOXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE SULPHATE, CISPLATIN, DOXORUBICIN, PIRARUBICIN. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from JAPAN on July 09, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma, stem cell transplant, prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, back pain, delirium, rhabdomyolysis, tremor. ENDOXAN dosage: unknown. During the same period patient was treated with GASTER D, MUCOSTA, DIFLUCAN, MAGNESIUM OXIDE, PURSENNID, UROMITEXAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on July 25, 2007. Female patient, 24 years of age, was diagnosed with t-cell type acute leukaemia, leukaemia recurrent prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: mucoepidermoid carcinoma. ENDOXAN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, METHOTREXATE, PREDNISOLONE, DEXAMETHASONE, DAUNORUBICIN, PIRARUBICIN, ELSPAR. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2007. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: lung disorder. ENDOXAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN. Patient died.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 06, 2007. Female patient, 59 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia. ENDOXAN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN HYDROCHLORIDE, CORTANCYL, RITUXAN. Patient was hospitalized. Patient recovered.
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Female patient, 73 years of age, was diagnosed with vasculitis, prophylaxis and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: neutrophil pelger-huet anomaly present. ENDOXAN dosage: unknown. During the same period patient was treated with BAKTAR, PREDONINE, GANCICLOVIR. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 06, 2007. Female patient, 68 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, endometrial cancer. ENDOXAN dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 170 Next >
This
drug has an active FDA Safety Alert